Melanoma: Does the run of success continue?
Novel immunotherapeutic constructs (MuSK antibodies)
Date
09 Oct 2016Session
Melanoma: Does the run of success continue?Presenters
Jason LukeAuthors
J.J. LukeAuthor affiliations
- Hematology/oncology, University of Chicago, Chicago/US
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
New checkpoints
Presenter: Jeffrey Weber
Session: Melanoma: Does the run of success continue?
Resources:
Slides